nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroflumethiazide—SLC12A1—urine—urinary bladder cancer	0.0472	0.102	CbGeAlD
Hydroflumethiazide—CA14—prostate gland—urinary bladder cancer	0.0189	0.0409	CbGeAlD
Hydroflumethiazide—SLC12A1—prostate gland—urinary bladder cancer	0.0169	0.0367	CbGeAlD
Hydroflumethiazide—CA14—seminal vesicle—urinary bladder cancer	0.016	0.0346	CbGeAlD
Hydroflumethiazide—CA7—renal system—urinary bladder cancer	0.0154	0.0334	CbGeAlD
Hydroflumethiazide—KCNMA1—prostate gland—urinary bladder cancer	0.0154	0.0333	CbGeAlD
Hydroflumethiazide—SLC12A3—renal system—urinary bladder cancer	0.0151	0.0328	CbGeAlD
Hydroflumethiazide—CA5B—prostate gland—urinary bladder cancer	0.0132	0.0286	CbGeAlD
Hydroflumethiazide—SLC12A1—epithelium—urinary bladder cancer	0.0125	0.027	CbGeAlD
Hydroflumethiazide—SLC12A3—female reproductive system—urinary bladder cancer	0.0121	0.0262	CbGeAlD
Hydroflumethiazide—SLC12A1—renal system—urinary bladder cancer	0.0116	0.025	CbGeAlD
Hydroflumethiazide—SLC12A1—urethra—urinary bladder cancer	0.0113	0.0246	CbGeAlD
Hydroflumethiazide—KCNMA1—epithelium—urinary bladder cancer	0.0113	0.0244	CbGeAlD
Hydroflumethiazide—KCNMA1—smooth muscle tissue—urinary bladder cancer	0.0109	0.0235	CbGeAlD
Hydroflumethiazide—CA9—female reproductive system—urinary bladder cancer	0.0109	0.0235	CbGeAlD
Hydroflumethiazide—Hyperglycaemia—Valrubicin—urinary bladder cancer	0.0105	0.0271	CcSEcCtD
Hydroflumethiazide—KCNMA1—renal system—urinary bladder cancer	0.0105	0.0227	CbGeAlD
Hydroflumethiazide—CA12—renal system—urinary bladder cancer	0.01	0.0217	CbGeAlD
Hydroflumethiazide—ATP1A1—prostate gland—urinary bladder cancer	0.00986	0.0214	CbGeAlD
Hydroflumethiazide—CA4—prostate gland—urinary bladder cancer	0.00912	0.0197	CbGeAlD
Hydroflumethiazide—CA5B—urethra—urinary bladder cancer	0.00884	0.0191	CbGeAlD
Hydroflumethiazide—KCNMA1—female reproductive system—urinary bladder cancer	0.00838	0.0181	CbGeAlD
Hydroflumethiazide—ATP1A1—seminal vesicle—urinary bladder cancer	0.00834	0.0181	CbGeAlD
Hydroflumethiazide—CA12—female reproductive system—urinary bladder cancer	0.00804	0.0174	CbGeAlD
Hydroflumethiazide—CA1—renal system—urinary bladder cancer	0.00795	0.0172	CbGeAlD
Hydroflumethiazide—CA4—seminal vesicle—urinary bladder cancer	0.00771	0.0167	CbGeAlD
Hydroflumethiazide—CA2—prostate gland—urinary bladder cancer	0.00756	0.0164	CbGeAlD
Hydroflumethiazide—ATP1A1—epithelium—urinary bladder cancer	0.00725	0.0157	CbGeAlD
Hydroflumethiazide—CA5B—female reproductive system—urinary bladder cancer	0.00721	0.0156	CbGeAlD
Hydroflumethiazide—ATP1A1—smooth muscle tissue—urinary bladder cancer	0.00698	0.0151	CbGeAlD
Hydroflumethiazide—Hyperuricaemia—Thiotepa—urinary bladder cancer	0.00693	0.0179	CcSEcCtD
Hydroflumethiazide—ATP1A1—renal system—urinary bladder cancer	0.00672	0.0146	CbGeAlD
Hydroflumethiazide—ATP1A1—urethra—urinary bladder cancer	0.0066	0.0143	CbGeAlD
Hydroflumethiazide—Blood uric acid increased—Thiotepa—urinary bladder cancer	0.00655	0.0169	CcSEcCtD
Hydroflumethiazide—CA5B—vagina—urinary bladder cancer	0.00652	0.0141	CbGeAlD
Hydroflumethiazide—CA2—seminal vesicle—urinary bladder cancer	0.00639	0.0138	CbGeAlD
Hydroflumethiazide—CA1—female reproductive system—urinary bladder cancer	0.00637	0.0138	CbGeAlD
Hydroflumethiazide—CA4—renal system—urinary bladder cancer	0.00621	0.0135	CbGeAlD
Hydroflumethiazide—CA4—urethra—urinary bladder cancer	0.0061	0.0132	CbGeAlD
Hydroflumethiazide—CA2—epithelium—urinary bladder cancer	0.00555	0.012	CbGeAlD
Hydroflumethiazide—Vasculitis—Gemcitabine—urinary bladder cancer	0.00554	0.0143	CcSEcCtD
Hydroflumethiazide—Hyperuricaemia—Cisplatin—urinary bladder cancer	0.00543	0.014	CcSEcCtD
Hydroflumethiazide—ATP1A1—female reproductive system—urinary bladder cancer	0.00538	0.0117	CbGeAlD
Hydroflumethiazide—CA2—smooth muscle tissue—urinary bladder cancer	0.00535	0.0116	CbGeAlD
Hydroflumethiazide—CA2—renal system—urinary bladder cancer	0.00515	0.0112	CbGeAlD
Hydroflumethiazide—Blood uric acid increased—Cisplatin—urinary bladder cancer	0.00513	0.0132	CcSEcCtD
Hydroflumethiazide—Leukopenia—Mitomycin—urinary bladder cancer	0.005	0.0129	CcSEcCtD
Hydroflumethiazide—Hyperuricaemia—Etoposide—urinary bladder cancer	0.00498	0.0128	CcSEcCtD
Hydroflumethiazide—CA4—female reproductive system—urinary bladder cancer	0.00498	0.0108	CbGeAlD
Hydroflumethiazide—KCNMA1—lymph node—urinary bladder cancer	0.0049	0.0106	CbGeAlD
Hydroflumethiazide—ATP1A1—vagina—urinary bladder cancer	0.00487	0.0105	CbGeAlD
Hydroflumethiazide—Asthenia—Valrubicin—urinary bladder cancer	0.00475	0.0122	CcSEcCtD
Hydroflumethiazide—Blood uric acid increased—Etoposide—urinary bladder cancer	0.0047	0.0121	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Valrubicin—urinary bladder cancer	0.00453	0.0117	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Mitomycin—urinary bladder cancer	0.00447	0.0115	CcSEcCtD
Hydroflumethiazide—Photosensitivity—Fluorouracil—urinary bladder cancer	0.0044	0.0113	CcSEcCtD
Hydroflumethiazide—Dizziness—Valrubicin—urinary bladder cancer	0.00438	0.0113	CcSEcCtD
Hydroflumethiazide—Anorexia—Mitomycin—urinary bladder cancer	0.00435	0.0112	CcSEcCtD
Hydroflumethiazide—CA5B—lymph node—urinary bladder cancer	0.00422	0.00913	CbGeAlD
Hydroflumethiazide—Vomiting—Valrubicin—urinary bladder cancer	0.00421	0.0109	CcSEcCtD
Hydroflumethiazide—Rash—Valrubicin—urinary bladder cancer	0.00417	0.0108	CcSEcCtD
Hydroflumethiazide—Dermatitis—Valrubicin—urinary bladder cancer	0.00417	0.0108	CcSEcCtD
Hydroflumethiazide—Headache—Valrubicin—urinary bladder cancer	0.00415	0.0107	CcSEcCtD
Hydroflumethiazide—CA2—female reproductive system—urinary bladder cancer	0.00413	0.00894	CbGeAlD
Hydroflumethiazide—Decreased appetite—Mitomycin—urinary bladder cancer	0.00396	0.0102	CcSEcCtD
Hydroflumethiazide—Nausea—Valrubicin—urinary bladder cancer	0.00393	0.0101	CcSEcCtD
Hydroflumethiazide—CA2—vagina—urinary bladder cancer	0.00373	0.00808	CbGeAlD
Hydroflumethiazide—CA1—lymph node—urinary bladder cancer	0.00372	0.00806	CbGeAlD
Hydroflumethiazide—Hyperglycaemia—Thiotepa—urinary bladder cancer	0.00364	0.00938	CcSEcCtD
Hydroflumethiazide—Jaundice—Thiotepa—urinary bladder cancer	0.00351	0.00904	CcSEcCtD
Hydroflumethiazide—Agranulocytosis—Thiotepa—urinary bladder cancer	0.00336	0.00865	CcSEcCtD
Hydroflumethiazide—Orthostatic hypotension—Cisplatin—urinary bladder cancer	0.00334	0.00862	CcSEcCtD
Hydroflumethiazide—Cramp muscle—Cisplatin—urinary bladder cancer	0.00329	0.0085	CcSEcCtD
Hydroflumethiazide—Asthenia—Mitomycin—urinary bladder cancer	0.00327	0.00844	CcSEcCtD
Hydroflumethiazide—Glycosuria—Epirubicin—urinary bladder cancer	0.0032	0.00824	CcSEcCtD
Hydroflumethiazide—ATP1A1—lymph node—urinary bladder cancer	0.00315	0.00682	CbGeAlD
Hydroflumethiazide—Diarrhoea—Mitomycin—urinary bladder cancer	0.00312	0.00805	CcSEcCtD
Hydroflumethiazide—Pancreatitis—Cisplatin—urinary bladder cancer	0.0031	0.00799	CcSEcCtD
Hydroflumethiazide—Hyperglycaemia—Gemcitabine—urinary bladder cancer	0.00306	0.00789	CcSEcCtD
Hydroflumethiazide—Photosensitivity reaction—Fluorouracil—urinary bladder cancer	0.00304	0.00785	CcSEcCtD
Hydroflumethiazide—Cramp muscle—Etoposide—urinary bladder cancer	0.00302	0.00778	CcSEcCtD
Hydroflumethiazide—Dizziness—Mitomycin—urinary bladder cancer	0.00302	0.00778	CcSEcCtD
Hydroflumethiazide—Hyperuricaemia—Methotrexate—urinary bladder cancer	0.00298	0.00769	CcSEcCtD
Hydroflumethiazide—Glycosuria—Doxorubicin—urinary bladder cancer	0.00296	0.00762	CcSEcCtD
Hydroflumethiazide—Jaundice cholestatic—Epirubicin—urinary bladder cancer	0.00295	0.0076	CcSEcCtD
Hydroflumethiazide—CA4—lymph node—urinary bladder cancer	0.00291	0.0063	CbGeAlD
Hydroflumethiazide—Vomiting—Mitomycin—urinary bladder cancer	0.0029	0.00748	CcSEcCtD
Hydroflumethiazide—Rash—Mitomycin—urinary bladder cancer	0.00288	0.00741	CcSEcCtD
Hydroflumethiazide—Dermatitis—Mitomycin—urinary bladder cancer	0.00287	0.00741	CcSEcCtD
Hydroflumethiazide—Headache—Mitomycin—urinary bladder cancer	0.00286	0.00737	CcSEcCtD
Hydroflumethiazide—Vasculitis—Methotrexate—urinary bladder cancer	0.00283	0.00731	CcSEcCtD
Hydroflumethiazide—Agranulocytosis—Gemcitabine—urinary bladder cancer	0.00282	0.00728	CcSEcCtD
Hydroflumethiazide—Blood uric acid increased—Methotrexate—urinary bladder cancer	0.00282	0.00726	CcSEcCtD
Hydroflumethiazide—Hyperuricaemia—Epirubicin—urinary bladder cancer	0.00279	0.00719	CcSEcCtD
Hydroflumethiazide—Agranulocytosis—Fluorouracil—urinary bladder cancer	0.00278	0.00716	CcSEcCtD
Hydroflumethiazide—Jaundice cholestatic—Doxorubicin—urinary bladder cancer	0.00273	0.00703	CcSEcCtD
Hydroflumethiazide—Nausea—Mitomycin—urinary bladder cancer	0.00271	0.00698	CcSEcCtD
Hydroflumethiazide—Blood uric acid increased—Epirubicin—urinary bladder cancer	0.00264	0.0068	CcSEcCtD
Hydroflumethiazide—Aplastic anaemia—Methotrexate—urinary bladder cancer	0.0026	0.0067	CcSEcCtD
Hydroflumethiazide—Agitation—Thiotepa—urinary bladder cancer	0.00258	0.00666	CcSEcCtD
Hydroflumethiazide—Hyperuricaemia—Doxorubicin—urinary bladder cancer	0.00258	0.00666	CcSEcCtD
Hydroflumethiazide—Jaundice—Etoposide—urinary bladder cancer	0.00252	0.00649	CcSEcCtD
Hydroflumethiazide—Leukopenia—Thiotepa—urinary bladder cancer	0.00252	0.00649	CcSEcCtD
Hydroflumethiazide—Blood uric acid increased—Doxorubicin—urinary bladder cancer	0.00244	0.00629	CcSEcCtD
Hydroflumethiazide—Aplastic anaemia—Epirubicin—urinary bladder cancer	0.00243	0.00627	CcSEcCtD
Hydroflumethiazide—CA2—lymph node—urinary bladder cancer	0.00241	0.00523	CbGeAlD
Hydroflumethiazide—Agranulocytosis—Etoposide—urinary bladder cancer	0.00241	0.00622	CcSEcCtD
Hydroflumethiazide—Photosensitivity—Methotrexate—urinary bladder cancer	0.00229	0.0059	CcSEcCtD
Hydroflumethiazide—Aplastic anaemia—Doxorubicin—urinary bladder cancer	0.00225	0.0058	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Thiotepa—urinary bladder cancer	0.00225	0.00579	CcSEcCtD
Hydroflumethiazide—Anorexia—Thiotepa—urinary bladder cancer	0.00219	0.00564	CcSEcCtD
Hydroflumethiazide—Photosensitivity—Epirubicin—urinary bladder cancer	0.00214	0.00552	CcSEcCtD
Hydroflumethiazide—Muscle spasms—Cisplatin—urinary bladder cancer	0.00212	0.00546	CcSEcCtD
Hydroflumethiazide—Leukopenia—Gemcitabine—urinary bladder cancer	0.00212	0.00546	CcSEcCtD
Hydroflumethiazide—Vascular purpura—Epirubicin—urinary bladder cancer	0.0021	0.00542	CcSEcCtD
Hydroflumethiazide—Leukopenia—Fluorouracil—urinary bladder cancer	0.00208	0.00536	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Thiotepa—urinary bladder cancer	0.00199	0.00514	CcSEcCtD
Hydroflumethiazide—Photosensitivity—Doxorubicin—urinary bladder cancer	0.00198	0.00511	CcSEcCtD
Hydroflumethiazide—Leukopenia—Cisplatin—urinary bladder cancer	0.00197	0.00509	CcSEcCtD
Hydroflumethiazide—Constipation—Thiotepa—urinary bladder cancer	0.00196	0.00506	CcSEcCtD
Hydroflumethiazide—Purpura—Epirubicin—urinary bladder cancer	0.00195	0.00503	CcSEcCtD
Hydroflumethiazide—Vascular purpura—Doxorubicin—urinary bladder cancer	0.00194	0.00501	CcSEcCtD
Hydroflumethiazide—Muscle spasms—Etoposide—urinary bladder cancer	0.00194	0.005	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Gemcitabine—urinary bladder cancer	0.00189	0.00487	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Fluorouracil—urinary bladder cancer	0.00186	0.00479	CcSEcCtD
Hydroflumethiazide—Anorexia—Gemcitabine—urinary bladder cancer	0.00184	0.00474	CcSEcCtD
Hydroflumethiazide—Urticaria—Thiotepa—urinary bladder cancer	0.00182	0.0047	CcSEcCtD
Hydroflumethiazide—Vertigo—Etoposide—urinary bladder cancer	0.00181	0.00468	CcSEcCtD
Hydroflumethiazide—Anorexia—Fluorouracil—urinary bladder cancer	0.00181	0.00466	CcSEcCtD
Hydroflumethiazide—Leukopenia—Etoposide—urinary bladder cancer	0.00181	0.00466	CcSEcCtD
Hydroflumethiazide—Purpura—Doxorubicin—urinary bladder cancer	0.0018	0.00465	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Cisplatin—urinary bladder cancer	0.00176	0.00454	CcSEcCtD
Hydroflumethiazide—Orthostatic hypotension—Epirubicin—urinary bladder cancer	0.00172	0.00442	CcSEcCtD
Hydroflumethiazide—Anorexia—Cisplatin—urinary bladder cancer	0.00171	0.00442	CcSEcCtD
Hydroflumethiazide—Pancreatitis—Methotrexate—urinary bladder cancer	0.0017	0.00439	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Thiotepa—urinary bladder cancer	0.00169	0.00436	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Gemcitabine—urinary bladder cancer	0.00168	0.00432	CcSEcCtD
Hydroflumethiazide—Constipation—Gemcitabine—urinary bladder cancer	0.00165	0.00425	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Fluorouracil—urinary bladder cancer	0.00165	0.00425	CcSEcCtD
Hydroflumethiazide—Asthenia—Thiotepa—urinary bladder cancer	0.00165	0.00424	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Etoposide—urinary bladder cancer	0.00161	0.00416	CcSEcCtD
Hydroflumethiazide—Pancreatitis—Epirubicin—urinary bladder cancer	0.00159	0.00411	CcSEcCtD
Hydroflumethiazide—Orthostatic hypotension—Doxorubicin—urinary bladder cancer	0.00159	0.00409	CcSEcCtD
Hydroflumethiazide—Photosensitivity reaction—Methotrexate—urinary bladder cancer	0.00158	0.00408	CcSEcCtD
Hydroflumethiazide—Anorexia—Etoposide—urinary bladder cancer	0.00157	0.00405	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Thiotepa—urinary bladder cancer	0.00157	0.00405	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Cisplatin—urinary bladder cancer	0.00156	0.00403	CcSEcCtD
Hydroflumethiazide—Dizziness—Thiotepa—urinary bladder cancer	0.00152	0.00391	CcSEcCtD
Hydroflumethiazide—Urticaria—Fluorouracil—urinary bladder cancer	0.00151	0.00389	CcSEcCtD
Hydroflumethiazide—Photosensitivity reaction—Epirubicin—urinary bladder cancer	0.00148	0.00382	CcSEcCtD
Hydroflumethiazide—Pancreatitis—Doxorubicin—urinary bladder cancer	0.00147	0.0038	CcSEcCtD
Hydroflumethiazide—Hyperglycaemia—Epirubicin—urinary bladder cancer	0.00146	0.00378	CcSEcCtD
Hydroflumethiazide—Vomiting—Thiotepa—urinary bladder cancer	0.00146	0.00376	CcSEcCtD
Hydroflumethiazide—Rash—Thiotepa—urinary bladder cancer	0.00145	0.00373	CcSEcCtD
Hydroflumethiazide—Dermatitis—Thiotepa—urinary bladder cancer	0.00144	0.00373	CcSEcCtD
Hydroflumethiazide—Agranulocytosis—Methotrexate—urinary bladder cancer	0.00144	0.00372	CcSEcCtD
Hydroflumethiazide—Headache—Thiotepa—urinary bladder cancer	0.00144	0.0037	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Etoposide—urinary bladder cancer	0.00143	0.00369	CcSEcCtD
Hydroflumethiazide—Jaundice—Epirubicin—urinary bladder cancer	0.00141	0.00364	CcSEcCtD
Hydroflumethiazide—Constipation—Etoposide—urinary bladder cancer	0.00141	0.00363	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.0014	0.0036	CcSEcCtD
Hydroflumethiazide—Asthenia—Gemcitabine—urinary bladder cancer	0.00138	0.00357	CcSEcCtD
Hydroflumethiazide—Photosensitivity reaction—Doxorubicin—urinary bladder cancer	0.00137	0.00354	CcSEcCtD
Hydroflumethiazide—Nausea—Thiotepa—urinary bladder cancer	0.00136	0.00351	CcSEcCtD
Hydroflumethiazide—Hyperglycaemia—Doxorubicin—urinary bladder cancer	0.00136	0.00349	CcSEcCtD
Hydroflumethiazide—Agranulocytosis—Epirubicin—urinary bladder cancer	0.00135	0.00348	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Cisplatin—urinary bladder cancer	0.00132	0.00342	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Gemcitabine—urinary bladder cancer	0.00132	0.0034	CcSEcCtD
Hydroflumethiazide—Urticaria—Etoposide—urinary bladder cancer	0.00131	0.00337	CcSEcCtD
Hydroflumethiazide—Jaundice—Doxorubicin—urinary bladder cancer	0.00131	0.00337	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Fluorouracil—urinary bladder cancer	0.0013	0.00335	CcSEcCtD
Hydroflumethiazide—Asthenia—Cisplatin—urinary bladder cancer	0.00129	0.00333	CcSEcCtD
Hydroflumethiazide—Dizziness—Fluorouracil—urinary bladder cancer	0.00125	0.00323	CcSEcCtD
Hydroflumethiazide—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.00125	0.00322	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Cisplatin—urinary bladder cancer	0.00123	0.00317	CcSEcCtD
Hydroflumethiazide—Vomiting—Gemcitabine—urinary bladder cancer	0.00123	0.00316	CcSEcCtD
Hydroflumethiazide—Rash—Gemcitabine—urinary bladder cancer	0.00122	0.00314	CcSEcCtD
Hydroflumethiazide—Dermatitis—Gemcitabine—urinary bladder cancer	0.00122	0.00313	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Etoposide—urinary bladder cancer	0.00121	0.00313	CcSEcCtD
Hydroflumethiazide—Headache—Gemcitabine—urinary bladder cancer	0.00121	0.00312	CcSEcCtD
Hydroflumethiazide—Vomiting—Fluorouracil—urinary bladder cancer	0.00121	0.00311	CcSEcCtD
Hydroflumethiazide—Rash—Fluorouracil—urinary bladder cancer	0.0012	0.00308	CcSEcCtD
Hydroflumethiazide—Dermatitis—Fluorouracil—urinary bladder cancer	0.00119	0.00308	CcSEcCtD
Hydroflumethiazide—Headache—Fluorouracil—urinary bladder cancer	0.00119	0.00306	CcSEcCtD
Hydroflumethiazide—Asthenia—Etoposide—urinary bladder cancer	0.00118	0.00305	CcSEcCtD
Hydroflumethiazide—Nausea—Gemcitabine—urinary bladder cancer	0.00115	0.00295	CcSEcCtD
Hydroflumethiazide—Vomiting—Cisplatin—urinary bladder cancer	0.00114	0.00295	CcSEcCtD
Hydroflumethiazide—Rash—Cisplatin—urinary bladder cancer	0.00113	0.00292	CcSEcCtD
Hydroflumethiazide—Dermatitis—Cisplatin—urinary bladder cancer	0.00113	0.00292	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Etoposide—urinary bladder cancer	0.00113	0.00291	CcSEcCtD
Hydroflumethiazide—Nausea—Fluorouracil—urinary bladder cancer	0.00113	0.00291	CcSEcCtD
Hydroflumethiazide—Dizziness—Etoposide—urinary bladder cancer	0.00109	0.00281	CcSEcCtD
Hydroflumethiazide—Muscle spasms—Epirubicin—urinary bladder cancer	0.00109	0.0028	CcSEcCtD
Hydroflumethiazide—Vertigo—Methotrexate—urinary bladder cancer	0.00109	0.0028	CcSEcCtD
Hydroflumethiazide—Leukopenia—Methotrexate—urinary bladder cancer	0.00108	0.00279	CcSEcCtD
Hydroflumethiazide—Nausea—Cisplatin—urinary bladder cancer	0.00107	0.00275	CcSEcCtD
Hydroflumethiazide—Vomiting—Etoposide—urinary bladder cancer	0.00105	0.0027	CcSEcCtD
Hydroflumethiazide—Agitation—Epirubicin—urinary bladder cancer	0.00104	0.00268	CcSEcCtD
Hydroflumethiazide—Rash—Etoposide—urinary bladder cancer	0.00104	0.00268	CcSEcCtD
Hydroflumethiazide—Dermatitis—Etoposide—urinary bladder cancer	0.00104	0.00268	CcSEcCtD
Hydroflumethiazide—Headache—Etoposide—urinary bladder cancer	0.00103	0.00266	CcSEcCtD
Hydroflumethiazide—Vertigo—Epirubicin—urinary bladder cancer	0.00102	0.00262	CcSEcCtD
Hydroflumethiazide—Leukopenia—Epirubicin—urinary bladder cancer	0.00101	0.00261	CcSEcCtD
Hydroflumethiazide—Muscle spasms—Doxorubicin—urinary bladder cancer	0.00101	0.0026	CcSEcCtD
Hydroflumethiazide—Nausea—Etoposide—urinary bladder cancer	0.000979	0.00252	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000966	0.00249	CcSEcCtD
Hydroflumethiazide—Agitation—Doxorubicin—urinary bladder cancer	0.000962	0.00248	CcSEcCtD
Hydroflumethiazide—Vertigo—Doxorubicin—urinary bladder cancer	0.000941	0.00243	CcSEcCtD
Hydroflumethiazide—Anorexia—Methotrexate—urinary bladder cancer	0.000941	0.00243	CcSEcCtD
Hydroflumethiazide—Leukopenia—Doxorubicin—urinary bladder cancer	0.000937	0.00242	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000904	0.00233	CcSEcCtD
Hydroflumethiazide—Anorexia—Epirubicin—urinary bladder cancer	0.00088	0.00227	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Methotrexate—urinary bladder cancer	0.000858	0.00221	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000837	0.00216	CcSEcCtD
Hydroflumethiazide—Anorexia—Doxorubicin—urinary bladder cancer	0.000815	0.0021	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Epirubicin—urinary bladder cancer	0.000803	0.00207	CcSEcCtD
Hydroflumethiazide—Constipation—Epirubicin—urinary bladder cancer	0.00079	0.00204	CcSEcCtD
Hydroflumethiazide—Urticaria—Methotrexate—urinary bladder cancer	0.000784	0.00202	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000743	0.00192	CcSEcCtD
Hydroflumethiazide—Urticaria—Epirubicin—urinary bladder cancer	0.000734	0.00189	CcSEcCtD
Hydroflumethiazide—Constipation—Doxorubicin—urinary bladder cancer	0.000731	0.00188	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000727	0.00187	CcSEcCtD
Hydroflumethiazide—CA5B—Metabolism—GSTZ1—urinary bladder cancer	0.00072	0.00479	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—GSTZ1—urinary bladder cancer	0.00072	0.00479	CbGpPWpGaD
Hydroflumethiazide—Asthenia—Methotrexate—urinary bladder cancer	0.000708	0.00183	CcSEcCtD
Hydroflumethiazide—CA9—Cellular responses to stress—RBX1—urinary bladder cancer	0.000702	0.00467	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Circadian rythm related genes—FAS—urinary bladder cancer	0.000694	0.00461	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—UGT2B7—urinary bladder cancer	0.000686	0.00456	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—GSTO2—urinary bladder cancer	0.000683	0.00454	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—NAT1—urinary bladder cancer	0.000683	0.00454	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—GSTO2—urinary bladder cancer	0.000683	0.00454	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—NAT1—urinary bladder cancer	0.000683	0.00454	CbGpPWpGaD
Hydroflumethiazide—Hypersensitivity—Epirubicin—urinary bladder cancer	0.00068	0.00175	CcSEcCtD
Hydroflumethiazide—Urticaria—Doxorubicin—urinary bladder cancer	0.000679	0.00175	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Methotrexate—urinary bladder cancer	0.000675	0.00174	CcSEcCtD
Hydroflumethiazide—CA12—Metabolism—GSTZ1—urinary bladder cancer	0.000667	0.00444	CbGpPWpGaD
Hydroflumethiazide—CA1—C-MYB transcription factor network—CCND1—urinary bladder cancer	0.000663	0.00441	CbGpPWpGaD
Hydroflumethiazide—Asthenia—Epirubicin—urinary bladder cancer	0.000663	0.00171	CcSEcCtD
Hydroflumethiazide—Dizziness—Methotrexate—urinary bladder cancer	0.000653	0.00168	CcSEcCtD
Hydroflumethiazide—CA9—HIF-1-alpha transcription factor network—EP300—urinary bladder cancer	0.000651	0.00433	CbGpPWpGaD
Hydroflumethiazide—CA1—C-MYB transcription factor network—CDKN1A—urinary bladder cancer	0.000641	0.00426	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—GSTO2—urinary bladder cancer	0.000632	0.00421	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—NAT1—urinary bladder cancer	0.000632	0.00421	CbGpPWpGaD
Hydroflumethiazide—Diarrhoea—Epirubicin—urinary bladder cancer	0.000632	0.00163	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.00063	0.00162	CcSEcCtD
Hydroflumethiazide—Vomiting—Methotrexate—urinary bladder cancer	0.000627	0.00162	CcSEcCtD
Hydroflumethiazide—CA5B—Metabolism—UGT2B7—urinary bladder cancer	0.000624	0.00415	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—UGT2B7—urinary bladder cancer	0.000624	0.00415	CbGpPWpGaD
Hydroflumethiazide—Rash—Methotrexate—urinary bladder cancer	0.000622	0.0016	CcSEcCtD
Hydroflumethiazide—Dermatitis—Methotrexate—urinary bladder cancer	0.000622	0.0016	CcSEcCtD
Hydroflumethiazide—Headache—Methotrexate—urinary bladder cancer	0.000618	0.00159	CcSEcCtD
Hydroflumethiazide—CA14—Metabolism—CYP4B1—urinary bladder cancer	0.000618	0.00411	CbGpPWpGaD
Hydroflumethiazide—Asthenia—Doxorubicin—urinary bladder cancer	0.000613	0.00158	CcSEcCtD
Hydroflumethiazide—Dizziness—Epirubicin—urinary bladder cancer	0.000611	0.00157	CcSEcCtD
Hydroflumethiazide—KCNMA1—Circadian rythm related genes—CDK4—urinary bladder cancer	0.000611	0.00406	CbGpPWpGaD
Hydroflumethiazide—CA1—C-MYB transcription factor network—EP300—urinary bladder cancer	0.00061	0.00406	CbGpPWpGaD
Hydroflumethiazide—Vomiting—Epirubicin—urinary bladder cancer	0.000587	0.00151	CcSEcCtD
Hydroflumethiazide—Nausea—Methotrexate—urinary bladder cancer	0.000586	0.00151	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000585	0.00151	CcSEcCtD
Hydroflumethiazide—CA14—Metabolism—SLC19A1—urinary bladder cancer	0.000583	0.00388	CbGpPWpGaD
Hydroflumethiazide—Rash—Epirubicin—urinary bladder cancer	0.000582	0.0015	CcSEcCtD
Hydroflumethiazide—Dermatitis—Epirubicin—urinary bladder cancer	0.000582	0.0015	CcSEcCtD
Hydroflumethiazide—Headache—Epirubicin—urinary bladder cancer	0.000579	0.00149	CcSEcCtD
Hydroflumethiazide—CA12—Metabolism—UGT2B7—urinary bladder cancer	0.000578	0.00385	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—PRSS3—urinary bladder cancer	0.000569	0.00378	CbGpPWpGaD
Hydroflumethiazide—Dizziness—Doxorubicin—urinary bladder cancer	0.000565	0.00146	CcSEcCtD
Hydroflumethiazide—CA5B—Metabolism—CYP4B1—urinary bladder cancer	0.000562	0.00374	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—CYP4B1—urinary bladder cancer	0.000562	0.00374	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Circadian rythm related genes—PPARG—urinary bladder cancer	0.000555	0.00369	CbGpPWpGaD
Hydroflumethiazide—Nausea—Epirubicin—urinary bladder cancer	0.000549	0.00141	CcSEcCtD
Hydroflumethiazide—SLC12A1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000547	0.00364	CbGpPWpGaD
Hydroflumethiazide—Vomiting—Doxorubicin—urinary bladder cancer	0.000543	0.0014	CcSEcCtD
Hydroflumethiazide—Rash—Doxorubicin—urinary bladder cancer	0.000539	0.00139	CcSEcCtD
Hydroflumethiazide—Dermatitis—Doxorubicin—urinary bladder cancer	0.000538	0.00139	CcSEcCtD
Hydroflumethiazide—Headache—Doxorubicin—urinary bladder cancer	0.000535	0.00138	CcSEcCtD
Hydroflumethiazide—CA4—Metabolism—GSTZ1—urinary bladder cancer	0.000532	0.00354	CbGpPWpGaD
Hydroflumethiazide—CA1—C-MYB transcription factor network—MYC—urinary bladder cancer	0.000532	0.00354	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—SLC19A1—urinary bladder cancer	0.000531	0.00353	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—SLC19A1—urinary bladder cancer	0.000531	0.00353	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—CYP4B1—urinary bladder cancer	0.000521	0.00346	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—PRSS3—urinary bladder cancer	0.000517	0.00344	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—PRSS3—urinary bladder cancer	0.000517	0.00344	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—GSTZ1—urinary bladder cancer	0.00051	0.00339	CbGpPWpGaD
Hydroflumethiazide—Nausea—Doxorubicin—urinary bladder cancer	0.000508	0.00131	CcSEcCtD
Hydroflumethiazide—CA4—Metabolism—GSTO2—urinary bladder cancer	0.000504	0.00335	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—NAT1—urinary bladder cancer	0.000504	0.00335	CbGpPWpGaD
Hydroflumethiazide—CA9—Cellular responses to stress—GSTP1—urinary bladder cancer	0.000498	0.00331	CbGpPWpGaD
Hydroflumethiazide—SLC12A3—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000497	0.0033	CbGpPWpGaD
Hydroflumethiazide—ATP1A1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000497	0.0033	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—SLC19A1—urinary bladder cancer	0.000492	0.00327	CbGpPWpGaD
Hydroflumethiazide—CA1—C-MYB transcription factor network—KRAS—urinary bladder cancer	0.000491	0.00327	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—GSTZ1—urinary bladder cancer	0.000489	0.00325	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—GSTO2—urinary bladder cancer	0.000483	0.00322	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—NAT1—urinary bladder cancer	0.000483	0.00322	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—PRSS3—urinary bladder cancer	0.000479	0.00319	CbGpPWpGaD
Hydroflumethiazide—CA9—Cellular responses to stress—CCNE1—urinary bladder cancer	0.000471	0.00314	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—GSTO2—urinary bladder cancer	0.000464	0.00308	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—NAT1—urinary bladder cancer	0.000464	0.00308	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—UGT2B7—urinary bladder cancer	0.000461	0.00307	CbGpPWpGaD
Hydroflumethiazide—CA9—Cellular responses to stress—SOD2—urinary bladder cancer	0.000459	0.00306	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—TYMP—urinary bladder cancer	0.000455	0.00302	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—UGT2B7—urinary bladder cancer	0.000442	0.00294	CbGpPWpGaD
Hydroflumethiazide—CA9—Cellular responses to stress—GPX1—urinary bladder cancer	0.000438	0.00291	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—IFNA2—urinary bladder cancer	0.000435	0.00289	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—GSTZ1—urinary bladder cancer	0.00043	0.00286	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—UGT2B7—urinary bladder cancer	0.000424	0.00282	CbGpPWpGaD
Hydroflumethiazide—CA1—C-MYB transcription factor network—HRAS—urinary bladder cancer	0.000418	0.00278	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—CYP4B1—urinary bladder cancer	0.000415	0.00276	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—TYMP—urinary bladder cancer	0.000414	0.00275	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—TYMP—urinary bladder cancer	0.000414	0.00275	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—NAT2—urinary bladder cancer	0.000411	0.00273	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—GSTO2—urinary bladder cancer	0.000408	0.00271	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—NAT1—urinary bladder cancer	0.000408	0.00271	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—CYP4B1—urinary bladder cancer	0.000398	0.00265	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—SLC19A1—urinary bladder cancer	0.000392	0.00261	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—TYMP—urinary bladder cancer	0.000383	0.00255	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—PRSS3—urinary bladder cancer	0.000382	0.00254	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—CYP4B1—urinary bladder cancer	0.000382	0.00254	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Circadian rythm related genes—PTEN—urinary bladder cancer	0.000381	0.00253	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—SLC19A1—urinary bladder cancer	0.000376	0.0025	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—NAT2—urinary bladder cancer	0.000374	0.00249	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—NAT2—urinary bladder cancer	0.000374	0.00249	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—UGT2B7—urinary bladder cancer	0.000373	0.00248	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—PRSS3—urinary bladder cancer	0.000366	0.00244	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Circadian rythm related genes—EP300—urinary bladder cancer	0.000363	0.00241	CbGpPWpGaD
Hydroflumethiazide—CA9—Cellular responses to stress—ATM—urinary bladder cancer	0.000363	0.00241	CbGpPWpGaD
Hydroflumethiazide—CA9—Cellular responses to stress—CDK4—urinary bladder cancer	0.000361	0.0024	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—SLC19A1—urinary bladder cancer	0.00036	0.0024	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—RRM2—urinary bladder cancer	0.000355	0.00236	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—PRSS3—urinary bladder cancer	0.000351	0.00234	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—NAT2—urinary bladder cancer	0.000346	0.0023	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—CYP4B1—urinary bladder cancer	0.000336	0.00223	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—HPGDS—urinary bladder cancer	0.000329	0.00219	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—ENO2—urinary bladder cancer	0.000329	0.00219	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—RRM2—urinary bladder cancer	0.000323	0.00215	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—RRM2—urinary bladder cancer	0.000323	0.00215	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—GSTT1—urinary bladder cancer	0.000319	0.00212	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—SLC19A1—urinary bladder cancer	0.000317	0.00211	CbGpPWpGaD
Hydroflumethiazide—CA9—Cellular responses to stress—CREBBP—urinary bladder cancer	0.000315	0.0021	CbGpPWpGaD
Hydroflumethiazide—CA9—Cellular responses to stress—RB1—urinary bladder cancer	0.000314	0.00209	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—PRSS3—urinary bladder cancer	0.000309	0.00205	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—PLAU—urinary bladder cancer	0.000309	0.00205	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—TYMP—urinary bladder cancer	0.000306	0.00203	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—RRM2—urinary bladder cancer	0.000299	0.00199	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—HPGDS—urinary bladder cancer	0.000299	0.00199	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—ENO2—urinary bladder cancer	0.000299	0.00199	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—ENO2—urinary bladder cancer	0.000299	0.00199	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—HPGDS—urinary bladder cancer	0.000299	0.00199	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—TYMP—urinary bladder cancer	0.000293	0.00195	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—GSTT1—urinary bladder cancer	0.00029	0.00193	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—GSTT1—urinary bladder cancer	0.00029	0.00193	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—TYMP—urinary bladder cancer	0.000281	0.00187	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—HPGDS—urinary bladder cancer	0.000277	0.00184	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—ENO2—urinary bladder cancer	0.000277	0.00184	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—NAT2—urinary bladder cancer	0.000276	0.00184	CbGpPWpGaD
Hydroflumethiazide—CA9—Cellular responses to stress—CDKN2A—urinary bladder cancer	0.000276	0.00184	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—GSTT1—urinary bladder cancer	0.000269	0.00179	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—NAT2—urinary bladder cancer	0.000265	0.00176	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—NQO1—urinary bladder cancer	0.000265	0.00176	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Circadian rythm related genes—TP53—urinary bladder cancer	0.00026	0.00173	CbGpPWpGaD
Hydroflumethiazide—SLC12A1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	0.000256	0.0017	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—CREBBP—urinary bladder cancer	0.000255	0.00169	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—NAT2—urinary bladder cancer	0.000254	0.00169	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—IGF1—urinary bladder cancer	0.000251	0.00167	CbGpPWpGaD
Hydroflumethiazide—CA9—Cellular responses to stress—CXCL8—urinary bladder cancer	0.00025	0.00166	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—TYMP—urinary bladder cancer	0.000247	0.00164	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—NQO1—urinary bladder cancer	0.000241	0.0016	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—NQO1—urinary bladder cancer	0.000241	0.0016	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—RRM2—urinary bladder cancer	0.000239	0.00159	CbGpPWpGaD
Hydroflumethiazide—ATP1A1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	0.000233	0.00155	CbGpPWpGaD
Hydroflumethiazide—SLC12A3—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	0.000233	0.00155	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—RHOA—urinary bladder cancer	0.00023	0.00153	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—RRM2—urinary bladder cancer	0.000229	0.00152	CbGpPWpGaD
Hydroflumethiazide—CA9—Cellular responses to stress—CDKN1A—urinary bladder cancer	0.000226	0.0015	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—NAT2—urinary bladder cancer	0.000223	0.00148	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—NQO1—urinary bladder cancer	0.000223	0.00148	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—GSTP1—urinary bladder cancer	0.000221	0.00147	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—ENO2—urinary bladder cancer	0.000221	0.00147	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—HPGDS—urinary bladder cancer	0.000221	0.00147	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—RRM2—urinary bladder cancer	0.000219	0.00146	CbGpPWpGaD
Hydroflumethiazide—CA9—Cellular responses to stress—EP300—urinary bladder cancer	0.000215	0.00143	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—GSTT1—urinary bladder cancer	0.000214	0.00142	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—ENO2—urinary bladder cancer	0.000212	0.00141	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—HPGDS—urinary bladder cancer	0.000212	0.00141	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—TYMS—urinary bladder cancer	0.000205	0.00137	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—GSTT1—urinary bladder cancer	0.000205	0.00137	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—HPGDS—urinary bladder cancer	0.000203	0.00135	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—ENO2—urinary bladder cancer	0.000203	0.00135	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—GSTM1—urinary bladder cancer	0.000203	0.00135	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—NCOR1—urinary bladder cancer	0.000203	0.00135	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—GSTP1—urinary bladder cancer	0.000201	0.00134	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—GSTP1—urinary bladder cancer	0.000201	0.00134	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—GSTT1—urinary bladder cancer	0.000197	0.00131	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—GPX1—urinary bladder cancer	0.000194	0.00129	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—IL2—urinary bladder cancer	0.000193	0.00129	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—RRM2—urinary bladder cancer	0.000193	0.00128	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Neuronal System—HRAS—urinary bladder cancer	0.000191	0.00127	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—ERCC2—urinary bladder cancer	0.000191	0.00127	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—TYMS—urinary bladder cancer	0.000187	0.00124	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—TYMS—urinary bladder cancer	0.000187	0.00124	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—GSTP1—urinary bladder cancer	0.000186	0.00124	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—NCOR1—urinary bladder cancer	0.000185	0.00123	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—GSTM1—urinary bladder cancer	0.000185	0.00123	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—GSTM1—urinary bladder cancer	0.000185	0.00123	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—NCOR1—urinary bladder cancer	0.000185	0.00123	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—MTHFR—urinary bladder cancer	0.000179	0.00119	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—HPGDS—urinary bladder cancer	0.000178	0.00119	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—ENO2—urinary bladder cancer	0.000178	0.00119	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—NQO1—urinary bladder cancer	0.000178	0.00118	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—GPX1—urinary bladder cancer	0.000177	0.00118	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—GPX1—urinary bladder cancer	0.000177	0.00118	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—ERCC2—urinary bladder cancer	0.000174	0.00115	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—ERCC2—urinary bladder cancer	0.000174	0.00115	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—EP300—urinary bladder cancer	0.000173	0.00115	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—GSTT1—urinary bladder cancer	0.000173	0.00115	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—TYMS—urinary bladder cancer	0.000173	0.00115	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—NCOR1—urinary bladder cancer	0.000171	0.00114	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—GSTM1—urinary bladder cancer	0.000171	0.00114	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—NQO1—urinary bladder cancer	0.000171	0.00114	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—SRC—urinary bladder cancer	0.000169	0.00112	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—GPX1—urinary bladder cancer	0.000164	0.00109	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—NQO1—urinary bladder cancer	0.000164	0.00109	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—MTHFR—urinary bladder cancer	0.000163	0.00109	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—MTHFR—urinary bladder cancer	0.000163	0.00109	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—ERCC2—urinary bladder cancer	0.000161	0.00107	CbGpPWpGaD
Hydroflumethiazide—CA9—Cellular responses to stress—TP53—urinary bladder cancer	0.000154	0.00102	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—MTHFR—urinary bladder cancer	0.000151	0.00101	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—GSTP1—urinary bladder cancer	0.000149	0.000988	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—PPARG—urinary bladder cancer	0.000146	0.000968	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—NQO1—urinary bladder cancer	0.000144	0.000957	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—GSTP1—urinary bladder cancer	0.000142	0.000947	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—CREBBP—urinary bladder cancer	0.00014	0.00093	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—KRAS—urinary bladder cancer	0.00014	0.000929	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—TYMS—urinary bladder cancer	0.000138	0.000918	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—GSTP1—urinary bladder cancer	0.000137	0.000908	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—NCOR1—urinary bladder cancer	0.000136	0.000908	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—GSTM1—urinary bladder cancer	0.000136	0.000908	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—PPARG—urinary bladder cancer	0.000132	0.00088	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—PPARG—urinary bladder cancer	0.000132	0.00088	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—TYMS—urinary bladder cancer	0.000132	0.00088	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—GSTM1—urinary bladder cancer	0.000131	0.00087	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—NCOR1—urinary bladder cancer	0.000131	0.00087	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—GPX1—urinary bladder cancer	0.000131	0.000869	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—ERCC2—urinary bladder cancer	0.000128	0.000853	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—CREBBP—urinary bladder cancer	0.000127	0.000846	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—CREBBP—urinary bladder cancer	0.000127	0.000846	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—TYMS—urinary bladder cancer	0.000127	0.000844	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—NCOR1—urinary bladder cancer	0.000125	0.000834	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—GSTM1—urinary bladder cancer	0.000125	0.000834	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—GPX1—urinary bladder cancer	0.000125	0.000833	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—TP53—urinary bladder cancer	0.000124	0.000825	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—ERCC2—urinary bladder cancer	0.000123	0.000818	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—PPARG—urinary bladder cancer	0.000123	0.000816	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—MTHFR—urinary bladder cancer	0.000121	0.000802	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—GPX1—urinary bladder cancer	0.00012	0.000799	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—GSTP1—urinary bladder cancer	0.00012	0.000798	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—HRAS—urinary bladder cancer	0.000119	0.000789	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—ERCC2—urinary bladder cancer	0.000118	0.000784	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—CREBBP—urinary bladder cancer	0.000118	0.000783	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—MTHFR—urinary bladder cancer	0.000116	0.000769	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—PTGS2—urinary bladder cancer	0.000114	0.000761	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—TYMS—urinary bladder cancer	0.000112	0.000742	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—MTHFR—urinary bladder cancer	0.000111	0.000737	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—NCOR1—urinary bladder cancer	0.00011	0.000733	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—GSTM1—urinary bladder cancer	0.00011	0.000733	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—GPX1—urinary bladder cancer	0.000106	0.000702	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—PTGS2—urinary bladder cancer	0.000104	0.000693	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—PTGS2—urinary bladder cancer	0.000104	0.000693	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—ERCC2—urinary bladder cancer	0.000104	0.000689	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—PTEN—urinary bladder cancer	9.98e-05	0.000664	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—PPARG—urinary bladder cancer	9.78e-05	0.00065	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—MTHFR—urinary bladder cancer	9.75e-05	0.000648	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—PTGS2—urinary bladder cancer	9.65e-05	0.000642	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—EP300—urinary bladder cancer	9.52e-05	0.000633	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—CREBBP—urinary bladder cancer	9.4e-05	0.000625	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—PPARG—urinary bladder cancer	9.38e-05	0.000624	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—PTEN—urinary bladder cancer	9.08e-05	0.000604	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—PTEN—urinary bladder cancer	9.08e-05	0.000604	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—CREBBP—urinary bladder cancer	9.01e-05	0.000599	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—PPARG—urinary bladder cancer	8.99e-05	0.000598	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—EP300—urinary bladder cancer	8.66e-05	0.000576	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—EP300—urinary bladder cancer	8.66e-05	0.000576	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—CREBBP—urinary bladder cancer	8.64e-05	0.000574	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—PTEN—urinary bladder cancer	8.41e-05	0.00056	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—EP300—urinary bladder cancer	8.02e-05	0.000534	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—PPARG—urinary bladder cancer	7.9e-05	0.000526	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—PTGS2—urinary bladder cancer	7.69e-05	0.000512	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—CREBBP—urinary bladder cancer	7.59e-05	0.000505	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—PTGS2—urinary bladder cancer	7.38e-05	0.000491	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—PTGS2—urinary bladder cancer	7.07e-05	0.00047	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—PTEN—urinary bladder cancer	6.71e-05	0.000446	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—PTEN—urinary bladder cancer	6.43e-05	0.000428	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—EP300—urinary bladder cancer	6.4e-05	0.000426	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—PTGS2—urinary bladder cancer	6.22e-05	0.000413	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—PTEN—urinary bladder cancer	6.17e-05	0.00041	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—EP300—urinary bladder cancer	6.13e-05	0.000408	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—EP300—urinary bladder cancer	5.88e-05	0.000391	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—PTEN—urinary bladder cancer	5.42e-05	0.000361	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—EP300—urinary bladder cancer	5.17e-05	0.000344	CbGpPWpGaD
